Refractory B-Cell Lymphoma
8 clinical trials · Condition
◉ Watch Refractory B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies (NCT05003141) | Qilu Puget Sound Biotherapeutics (dba Sound Biologics) | 2021-11-15 |
| Study of CAR-T Therapy in Older Patients (NCT04300998) | Memorial Sloan Kettering Cancer Center | 2020-03-04 |
| Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma (NCT03690310) | Allife Medical Science and Technology Co., Ltd. | 2019-03-01 |
| Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma (NCT03692767) | Allife Medical Science and Technology Co., Ltd. | 2019-03-01 |
| Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma (NCT03824951) | Allife Medical Science and Technology Co., Ltd. | 2019-02-01 |
| Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma (NCT03824964) | Allife Medical Science and Technology Co., Ltd. | 2019-02-01 |
Track Refractory B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.